Delivery Order SPE2DR25D2006-SPE2DR26F57VM
- Not listed
- The Defense Logistics Agency awarded a $2,899.88 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Aprepitant 125 mg capsules in unit dose packaging (6-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 13, 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a delivery order valued at $2,505.27 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (5 count). The contract, executed on December 17, 2025, with an ultimate completion date of December 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,247.16 to AmerisourceBergen Drug Corp for Aprepitant 125 mg capsule unit dose packages (quantity 6). This non-set-aside, firm fixed price delivery order was awarded on October 20, 2025, with an ultimate completion date of October 21, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and headquarters. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order valued at $1,459.88 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (quantity 5) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $35,787.92 to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules in unit dose packages of six. The award, issued on February 4, 2026, carries an ultimate completion date of February 5, 2026, and employs firm fixed-price pricing with no set-aside designation. The contract was competitively awarded to AmerisourceBergen's corporate office, which maintains its place of performance in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,792.44 delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules (6-count units) under a firm fixed price contract. This non-set-aside award was issued on December 12, 2025, with an ultimate completion date of December 15, 2025. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,373.58 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging. This is a firm fixed-price, competitively awarded contract with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of February 4, 2026. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Aprepitant 80 mg capsule unit dose packages in quantities of six, with a contract ceiling value of $10,700.65. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and the order is scheduled for completion...
- The Defense Logistics Agency awarded a delivery order valued at $5,152.18 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packages of five. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at up to $999,999,999.00 through December 2026. The contract specifies performance at the awardee's facility...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsules with a ceiling value of $1,842.89. This competitively awarded, firm fixed-price delivery order was issued on December 15, 2025, with an ultimate completion date of December 16, 2025. The pharmaceutical product will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F57VMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,127.84 to AmerisourceBergen Drug Corp for Aprepitant 125 mg capsule unit dose packages (6 count) on February 3, 2026, with completion scheduled for February 4, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. This delivery order represents a routine pharmaceutical supply transaction supporting the Defense Health Agency and other federal healthcare systems. Aprepitant is an antiemetic medication commonly used in medical settings, particularly for chemotherapy-related nausea management. The order fulfills critical pharmaceutical supply requirements through AmerisourceBergen's comprehensive global pharmaceutical support vehicle, which enables the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the underlying $999,999,999.00 IDC with DLA through December 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 2/2/26 |